Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...

The firm's analysts think highly of Target's long-term prospects, despite cutting their price target for the fifth time since ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

An assessment by UBS says Bristol Myers Squibb and Pfizer would be worst hit among US companies if Mr Trump’s threatened ...

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

Discover Seer, Inc.'s Q1 2025 performance with $4.2M revenue, robust proteomics study milestones, and 24% growth guidance amidst macroeconomic challenges.

U.S.-based LNG company New Fortress Energy said on Tuesday it would push its quarterly filing with the U.S. securities ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Global pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...

The company held firm with its full-year profit growth outlook, as the impact of tariffs is expected to be limited. Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is ...